Organogenesis Holdings Inc. Profile Avatar - Palmy Investing

Organogenesis Holdings Inc.

Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products inclu…

Drug Manufacturers - Specialty & Generic
US, Canton [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Organogenesis Holdings Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of ORGO's Analysis
CIK: 1661181 CUSIP: 68621F102 ISIN: US68621F1021 LEI: - UEI: -
Secondary Listings
ORGO has no secondary listings inside our databases.